Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.

Identifieur interne : 000057 ( Main/Exploration ); précédent : 000056; suivant : 000058

Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.

Auteurs : Michelle Murti [Canada] ; Christina K. Fung [Canada] ; Kathy Chan [Canada] ; Mark Bigham [Canada]

Source :

RBID : pubmed:29502884

Descripteurs français

English descriptors

Abstract

To assess the duration of antiviral prophylaxis (AP), we conducted a retrospective outbreak review over 3 seasons, looking for acute respiratory illness (ARI) onset after 5 days of AP. Of 114 facility-level outbreaks with 352 unit-level outbreaks, we found only 1 case of laboratory-confirmed influenza after 5 days of AP. New cases of ARI after 5 days of AP should be investigated, and recommendations for AP duration could be shortened to 7-8 days or less.

DOI: 10.1016/j.ajic.2018.01.004
PubMed: 29502884


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.</title>
<author>
<name sortKey="Murti, Michelle" sort="Murti, Michelle" uniqKey="Murti M" first="Michelle" last="Murti">Michelle Murti</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fraser Health Authority, Surrey, Canada. Electronic address: Michelle.murti@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fung, Christina K" sort="Fung, Christina K" uniqKey="Fung C" first="Christina K" last="Fung">Christina K. Fung</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chan, Kathy" sort="Chan, Kathy" uniqKey="Chan K" first="Kathy" last="Chan">Kathy Chan</name>
<affiliation wicri:level="4">
<nlm:affiliation>University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bigham, Mark" sort="Bigham, Mark" uniqKey="Bigham M" first="Mark" last="Bigham">Mark Bigham</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29502884</idno>
<idno type="pmid">29502884</idno>
<idno type="doi">10.1016/j.ajic.2018.01.004</idno>
<idno type="wicri:Area/Main/Corpus">000052</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000052</idno>
<idno type="wicri:Area/Main/Curation">000052</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000052</idno>
<idno type="wicri:Area/Main/Exploration">000052</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.</title>
<author>
<name sortKey="Murti, Michelle" sort="Murti, Michelle" uniqKey="Murti M" first="Michelle" last="Murti">Michelle Murti</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fraser Health Authority, Surrey, Canada. Electronic address: Michelle.murti@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fung, Christina K" sort="Fung, Christina K" uniqKey="Fung C" first="Christina K" last="Fung">Christina K. Fung</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chan, Kathy" sort="Chan, Kathy" uniqKey="Chan K" first="Kathy" last="Chan">Kathy Chan</name>
<affiliation wicri:level="4">
<nlm:affiliation>University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bigham, Mark" sort="Bigham, Mark" uniqKey="Bigham M" first="Mark" last="Bigham">Mark Bigham</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">American journal of infection control</title>
<idno type="eISSN">1527-3296</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral Agents (administration & dosage)</term>
<term>British Columbia (epidemiology)</term>
<term>Chemoprevention (methods)</term>
<term>Cross Infection (epidemiology)</term>
<term>Cross Infection (pathology)</term>
<term>Cross Infection (prevention & control)</term>
<term>Disease Outbreaks</term>
<term>Health Facilities</term>
<term>Humans</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (pathology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Long-Term Care</term>
<term>Retrospective Studies</term>
<term>Time</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antiviraux (administration et posologie)</term>
<term>Chimioprévention ()</term>
<term>Colombie-Britannique (épidémiologie)</term>
<term>Flambées de maladies</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (anatomopathologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Infection croisée ()</term>
<term>Infection croisée (anatomopathologie)</term>
<term>Infection croisée (épidémiologie)</term>
<term>Soins de longue durée</term>
<term>Temps</term>
<term>Établissements de santé</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>British Columbia</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infection croisée</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Cross Infection</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Chemoprevention</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Cross Infection</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Cross Infection</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Colombie-Britannique</term>
<term>Grippe humaine</term>
<term>Infection croisée</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Disease Outbreaks</term>
<term>Health Facilities</term>
<term>Humans</term>
<term>Long-Term Care</term>
<term>Retrospective Studies</term>
<term>Time</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Chimioprévention</term>
<term>Flambées de maladies</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Infection croisée</term>
<term>Soins de longue durée</term>
<term>Temps</term>
<term>Établissements de santé</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To assess the duration of antiviral prophylaxis (AP), we conducted a retrospective outbreak review over 3 seasons, looking for acute respiratory illness (ARI) onset after 5 days of AP. Of 114 facility-level outbreaks with 352 unit-level outbreaks, we found only 1 case of laboratory-confirmed influenza after 5 days of AP. New cases of ARI after 5 days of AP should be investigated, and recommendations for AP duration could be shortened to 7-8 days or less.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29502884</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>09</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1527-3296</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>46</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2018</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>American journal of infection control</Title>
<ISOAbbreviation>Am J Infect Control</ISOAbbreviation>
</Journal>
<ArticleTitle>Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.</ArticleTitle>
<Pagination>
<MedlinePgn>1077-1079</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0196-6553(18)30005-1</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajic.2018.01.004</ELocationID>
<Abstract>
<AbstractText>To assess the duration of antiviral prophylaxis (AP), we conducted a retrospective outbreak review over 3 seasons, looking for acute respiratory illness (ARI) onset after 5 days of AP. Of 114 facility-level outbreaks with 352 unit-level outbreaks, we found only 1 case of laboratory-confirmed influenza after 5 days of AP. New cases of ARI after 5 days of AP should be investigated, and recommendations for AP duration could be shortened to 7-8 days or less.</AbstractText>
<CopyrightInformation>Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Murti</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Fraser Health Authority, Surrey, Canada. Electronic address: Michelle.murti@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fung</LastName>
<ForeName>Christina K</ForeName>
<Initials>CK</Initials>
<AffiliationInfo>
<Affiliation>Fraser Health Authority, Surrey, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Kathy</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>University of Toronto, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bigham</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Fraser Health Authority, Surrey, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>03</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Infect Control</MedlineTA>
<NlmUniqueID>8004854</NlmUniqueID>
<ISSNLinking>0196-6553</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001955" MajorTopicYN="N" Type="Geographic">British Columbia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018890" MajorTopicYN="N">Chemoprevention</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Antiviral</Keyword>
<Keyword MajorTopicYN="Y">Influenza</Keyword>
<Keyword MajorTopicYN="Y">Long-term care facility</Keyword>
<Keyword MajorTopicYN="Y">Outbreak</Keyword>
<Keyword MajorTopicYN="Y">Prophylaxis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>10</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>01</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>01</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>3</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>3</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29502884</ArticleId>
<ArticleId IdType="pii">S0196-6553(18)30005-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.ajic.2018.01.004</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Murti, Michelle" sort="Murti, Michelle" uniqKey="Murti M" first="Michelle" last="Murti">Michelle Murti</name>
</noRegion>
<name sortKey="Bigham, Mark" sort="Bigham, Mark" uniqKey="Bigham M" first="Mark" last="Bigham">Mark Bigham</name>
<name sortKey="Chan, Kathy" sort="Chan, Kathy" uniqKey="Chan K" first="Kathy" last="Chan">Kathy Chan</name>
<name sortKey="Fung, Christina K" sort="Fung, Christina K" uniqKey="Fung C" first="Christina K" last="Fung">Christina K. Fung</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000057 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000057 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29502884
   |texte=   Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29502884" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020